|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 24500 |
FusionGeneSummary for NME7_TIPRL |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: NME7_TIPRL | Fusion gene ID: 24500 | Hgene | Tgene | Gene symbol | NME7 | TIPRL | Gene ID | 29922 | 261726 |
| Gene name | NME/NM23 family member 7 | TOR signaling pathway regulator | |
| Synonyms | CFAP67|MN23H7|NDK 7|NDK7|nm23-H7 | TIP|TIP41|TIPRL1 | |
| Cytomap | 1q24.2 | 1q24.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | nucleoside diphosphate kinase 7NDP kinase 7cilia and flagella associated protein 67non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase) | TIP41-like proteinTIP41, TOR signaling pathway regulator-likeputative MAPK-activating protein PM10type 2A-interacting protein | |
| Modification date | 20180522 | 20180523 | |
| UniProtAcc | Q9Y5B8 | O75663 | |
| Ensembl transtripts involved in fusion gene | ENST00000472647, ENST00000367811, ENST00000469474, | ENST00000367833, ENST00000367830, | |
| Fusion gene scores | * DoF score | 5 X 3 X 3=45 | 3 X 3 X 2=18 |
| # samples | 5 | 3 | |
| ** MAII score | log2(5/45*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: NME7 [Title/Abstract] AND TIPRL [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | TIPRL | GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 17384681 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | BLCA | TCGA-FD-A3SJ-01A | NME7 | chr1 | 169292355 | - | TIPRL | chr1 | 168153140 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000472647 | ENST00000367833 | NME7 | chr1 | 169292355 | - | TIPRL | chr1 | 168153140 | + |
| Frame-shift | ENST00000472647 | ENST00000367830 | NME7 | chr1 | 169292355 | - | TIPRL | chr1 | 168153140 | + |
| In-frame | ENST00000367811 | ENST00000367833 | NME7 | chr1 | 169292355 | - | TIPRL | chr1 | 168153140 | + |
| In-frame | ENST00000367811 | ENST00000367830 | NME7 | chr1 | 169292355 | - | TIPRL | chr1 | 168153140 | + |
| 5UTR-3CDS | ENST00000469474 | ENST00000367833 | NME7 | chr1 | 169292355 | - | TIPRL | chr1 | 168153140 | + |
| 5UTR-3CDS | ENST00000469474 | ENST00000367830 | NME7 | chr1 | 169292355 | - | TIPRL | chr1 | 168153140 | + |
Top |
FusionProtFeatures for NME7_TIPRL |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| NME7 | TIPRL |
| Major role in the synthesis of nucleoside triphosphatesother than ATP. The ATP gamma phosphate is transferred to the NDPbeta phosphate via a ping-pong mechanism, using a phosphorylatedactive-site intermediate. | May be a allosteric regulator of serine/threonine-protein phosphatase 2A (PP2A). Isoform 1 inhibits catalyticactivity of the PP2A(D) core complex in vitro. The PP2A(C):TIPRLcomplex does not show phosphatase activity. Acts as negativeregulator of serine/threonine-protein phosphatase 4 probably byinhibiting the formation of the active PPP4C:PPP4R2 complex; thefunction is proposed to implicate it in DNA damage response bypromoting H2AFX phosphorylated on Ser-140 (gamma-H2AFX). May playa role in the regulation of ATM/ATR signaling pathway controllingDNA replication and repair. {ECO:0000269|PubMed:17384681,ECO:0000269|PubMed:26717153}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for NME7_TIPRL |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_NME7_ENST00000367811_chr1_169292355_-_TIPRL_ENST00000367833_chr1_168153140_+_331aa MNHSERFVFIAEWYDPNASLLRRYELLFYPGDGSVEMHDVKNHRTFLKRTKYDNLHLEDLFIGNKVNVFSRQLVLIDYGDQYTARQLGSR KEKLADELHMPSLPEMMFGDNVLRIQHGSGFGIEFNATDALRCVNNYQGMLKVACAEEWQESRTEGEHSKEVIKPYDWTYTTDYKGTLLG ESLKLKVVPTTDHIDTEKLKAREQIKFFEEVLLFEDELHDHGVSSLSVKIRVMPSSFFLLLRFFLRIDGVLIRMNDTRLYHEADKTYMLR >In-frame_NME7_ENST00000367811_chr1_169292355_-_TIPRL_ENST00000367830_chr1_168153140_+_237aa MNHSERFVFIAEWYDPNASLLRRYELLFYPGDGSVEMHDVKNHRTFLKRTKYDNLHLEDLFIGNKVNVFSRQLVLIDYGDQYTARQLGSR KEKLADELHMPSLPEMMFGDNVLRIQHGSGFGIEFNATDALRCVNNYQGMLKVACAEEWQESRTEGEHSKEVIKPYDWTYTTDYKGTLLG |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_NME7_ENST00000367811_chr1_169292355_-_TIPRL_ENST00000367833_chr1_168153140_+_993nt ATGAATCATAGTGAAAGATTCGTTTTCATTGCAGAGTGGTATGATCCAAATGCTTCACTTCTTCGACGTTATGAGCTTTTATTTTACCCA GGGGATGGATCTGTTGAAATGCATGATGTAAAGAATCATCGCACCTTTTTAAAGCGGACCAAATATGATAACCTGCACTTGGAAGATTTA TTTATAGGCAACAAAGTGAATGTCTTTTCTCGACAACTGGTATTAATTGACTATGGGGATCAATATACAGCTCGCCAGCTGGGCAGTAGG AAAGAAAAATTAGCCGATGAATTACATATGCCATCTCTCCCTGAAATGATGTTTGGAGACAACGTTTTAAGAATCCAGCATGGGTCTGGC TTTGGAATTGAGTTCAATGCTACAGATGCGTTAAGATGTGTAAACAACTACCAAGGAATGCTTAAAGTGGCCTGTGCTGAAGAGTGGCAA GAAAGCAGGACGGAGGGTGAACACTCCAAAGAGGTTATTAAACCATATGATTGGACCTATACAACAGATTATAAGGGAACCTTACTTGGA GAATCTCTTAAGTTAAAGGTTGTACCTACAACAGATCATATAGATACAGAAAAATTGAAAGCCAGAGAACAGATTAAGTTTTTTGAAGAA GTTCTCCTTTTTGAGGATGAACTTCATGATCATGGAGTTTCAAGCCTGAGTGTGAAGATTAGAGTAATGCCTTCTAGCTTTTTCCTGCTG TTGCGGTTTTTCTTGAGAATTGATGGGGTGCTTATCAGAATGAATGACACGAGACTTTACCATGAGGCTGACAAGACCTACATGTTACGA GAATATACGTCACGAGAAAGCAAAATTTCTAGTTTGATGCATGTTCCACCTTCCCTCTTCACGGAACCTAATGAAATATCCCAGTATTTA CCAATAAAGGAAGCAGTTTGTGAGAAGCTAATATTTCCAGAAAGAATTGATCCTAACCCAGCAGACTCACAAAAAAGTACACAAGTGGAA >In-frame_NME7_ENST00000367811_chr1_169292355_-_TIPRL_ENST00000367830_chr1_168153140_+_711nt ATGAATCATAGTGAAAGATTCGTTTTCATTGCAGAGTGGTATGATCCAAATGCTTCACTTCTTCGACGTTATGAGCTTTTATTTTACCCA GGGGATGGATCTGTTGAAATGCATGATGTAAAGAATCATCGCACCTTTTTAAAGCGGACCAAATATGATAACCTGCACTTGGAAGATTTA TTTATAGGCAACAAAGTGAATGTCTTTTCTCGACAACTGGTATTAATTGACTATGGGGATCAATATACAGCTCGCCAGCTGGGCAGTAGG AAAGAAAAATTAGCCGATGAATTACATATGCCATCTCTCCCTGAAATGATGTTTGGAGACAACGTTTTAAGAATCCAGCATGGGTCTGGC TTTGGAATTGAGTTCAATGCTACAGATGCGTTAAGATGTGTAAACAACTACCAAGGAATGCTTAAAGTGGCCTGTGCTGAAGAGTGGCAA GAAAGCAGGACGGAGGGTGAACACTCCAAAGAGGTTATTAAACCATATGATTGGACCTATACAACAGATTATAAGGGAACCTTACTTGGA GAATCTCTTAAGTTAAAGGTTGTACCTACAACAGATCATATAGATACAGAAAAATTGAAAGCCAGAGAACAGATTAAGTTTTTTGAAGAA |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_NME7_ENST00000367811_chr1_169292355_-_TIPRL_ENST00000367833_chr1_168153140_+_1916nt GGAAGTAAAACTGCCGGAAACAGAATAATGGCGTCTCGTAGCCCCAGGCGACAGCGTGGAGGGGCGGGTCTGTCGATTGGATGAACGCAG CTGAGATTACTCCCAGCCACTAAGGACGAAGAGGTGGGGCGGTGGCGTCCCACGCCTCGTGCGACAGTGGGCGGGGCTTTGTTGCCTGAG TAACCGTATGATGGTGGTGGTGGTGGTGTCTTCCTGTCTCAACGATACCTATTTTCTAGTGCTGAGATCCTGAGACAATGAATCATAGTG AAAGATTCGTTTTCATTGCAGAGTGGTATGATCCAAATGCTTCACTTCTTCGACGTTATGAGCTTTTATTTTACCCAGGGGATGGATCTG TTGAAATGCATGATGTAAAGAATCATCGCACCTTTTTAAAGCGGACCAAATATGATAACCTGCACTTGGAAGATTTATTTATAGGCAACA AAGTGAATGTCTTTTCTCGACAACTGGTATTAATTGACTATGGGGATCAATATACAGCTCGCCAGCTGGGCAGTAGGAAAGAAAAATTAG CCGATGAATTACATATGCCATCTCTCCCTGAAATGATGTTTGGAGACAACGTTTTAAGAATCCAGCATGGGTCTGGCTTTGGAATTGAGT TCAATGCTACAGATGCGTTAAGATGTGTAAACAACTACCAAGGAATGCTTAAAGTGGCCTGTGCTGAAGAGTGGCAAGAAAGCAGGACGG AGGGTGAACACTCCAAAGAGGTTATTAAACCATATGATTGGACCTATACAACAGATTATAAGGGAACCTTACTTGGAGAATCTCTTAAGT TAAAGGTTGTACCTACAACAGATCATATAGATACAGAAAAATTGAAAGCCAGAGAACAGATTAAGTTTTTTGAAGAAGTTCTCCTTTTTG AGGATGAACTTCATGATCATGGAGTTTCAAGCCTGAGTGTGAAGATTAGAGTAATGCCTTCTAGCTTTTTCCTGCTGTTGCGGTTTTTCT TGAGAATTGATGGGGTGCTTATCAGAATGAATGACACGAGACTTTACCATGAGGCTGACAAGACCTACATGTTACGAGAATATACGTCAC GAGAAAGCAAAATTTCTAGTTTGATGCATGTTCCACCTTCCCTCTTCACGGAACCTAATGAAATATCCCAGTATTTACCAATAAAGGAAG CAGTTTGTGAGAAGCTAATATTTCCAGAAAGAATTGATCCTAACCCAGCAGACTCACAAAAAAGTACACAAGTGGAATAAAATGTGATAC AACATATACTCACTATGGAATCTGACTGGACACCTTGGCTATTTGTAAGGGGTTATTTTTATTATGAGAATTAATTGCCTTGTTTATGTA CAGATTTTCTGTAGCCTTAAAGGAAAAAAAAATAAAGATCGTTACAGGCAGGTTTCACTCAACTGCTGTTTGTACTGTCTGTCTTCACAT TCATATTCCAGATTTATATTTTCTGGAGTTAAATTTGGATGATTTCTAAATTATCACAAAGTGGGACCTCAGCAGTAGTGATGTGTGTGT CTCATGAGCAGTGAGCACAGTCTGCATTCATCATGAAACACTATCTTCTACCAGGAGGAGGTTAATGTAAATCACCAAATCCCAATGCCT TGTGACTTTCATAGGATTCCTGATCATGCATGTTGATGTACTGGCTCTTCACTTTGGGCTTTCTGATGTTTATTCACACCTTTGGAGAGT TGCAACTTGCCACATACGAAATTAGTCTCATAGTGTAGTGAACTTCAACCCCAAAATTTTAAAAATGTATTTCCCCCCAGTTTTAAATTG CCTTTGAAATTTAAAAAAAAAAAATTTAGACTTAGTACCAGAACCAAAAATACCTAGATTTTTGGAGAACTTATTACATACATAGAAACA >In-frame_NME7_ENST00000367811_chr1_169292355_-_TIPRL_ENST00000367830_chr1_168153140_+_1135nt GGAAGTAAAACTGCCGGAAACAGAATAATGGCGTCTCGTAGCCCCAGGCGACAGCGTGGAGGGGCGGGTCTGTCGATTGGATGAACGCAG CTGAGATTACTCCCAGCCACTAAGGACGAAGAGGTGGGGCGGTGGCGTCCCACGCCTCGTGCGACAGTGGGCGGGGCTTTGTTGCCTGAG TAACCGTATGATGGTGGTGGTGGTGGTGTCTTCCTGTCTCAACGATACCTATTTTCTAGTGCTGAGATCCTGAGACAATGAATCATAGTG AAAGATTCGTTTTCATTGCAGAGTGGTATGATCCAAATGCTTCACTTCTTCGACGTTATGAGCTTTTATTTTACCCAGGGGATGGATCTG TTGAAATGCATGATGTAAAGAATCATCGCACCTTTTTAAAGCGGACCAAATATGATAACCTGCACTTGGAAGATTTATTTATAGGCAACA AAGTGAATGTCTTTTCTCGACAACTGGTATTAATTGACTATGGGGATCAATATACAGCTCGCCAGCTGGGCAGTAGGAAAGAAAAATTAG CCGATGAATTACATATGCCATCTCTCCCTGAAATGATGTTTGGAGACAACGTTTTAAGAATCCAGCATGGGTCTGGCTTTGGAATTGAGT TCAATGCTACAGATGCGTTAAGATGTGTAAACAACTACCAAGGAATGCTTAAAGTGGCCTGTGCTGAAGAGTGGCAAGAAAGCAGGACGG AGGGTGAACACTCCAAAGAGGTTATTAAACCATATGATTGGACCTATACAACAGATTATAAGGGAACCTTACTTGGAGAATCTCTTAAGT TAAAGGTTGTACCTACAACAGATCATATAGATACAGAAAAATTGAAAGCCAGAGAACAGATTAAGTTTTTTGAAGAAGTTCTCCTTTTTG AGGATGAACTTCATGATCATGGAGTTTCAAGCCTGAGTGTGAAGATTCCTGGTGGCGGGCACCTGTAGTCCCAGCTACTCGGGAGGCTGA GGCAGGAGAAGCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCTGAGATCGCACCACTGCACTCCAGCCCTCCAGCCTGGGCGACAGAGC |
Top |
FusionGenePPI for NME7_TIPRL |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| NME7 | FKBP6, NT5C2, TCHP, KRT18, ZNF263, CDK5RAP2, TUFT1, DDX1, OFD1, MAP4K4, TNIP1, YWHAQ, LATS2, TUBG1, TUBGCP2, TUBGCP3, GOLGA2, ZBTB48, NAB2, NEFL, REL, TRIM27, TCF4, FOSL1, MYOT, CDC42EP2, CCHCR1, CEP72, KIAA1598, LNX1, SYCE1, C1orf189, CSPP1, MZT2B, WNT2, GLUL, LPPR2, PCED1B, BTRC, SSX2IP, PCM1, CEP170, KIAA0753, CEP104, CEP162, CEP290, CNTROB, CEP128, CEP135, CEP63, CEP89, CNTRL, NINL, NIN, ODF2, RPGRIP1L, STIL, LGALS3BP, SCAF11, TUBGCP4, TUBGCP5, NEDD1, MZT1, TXNDC12, TUBG2, PRICKLE3, KIAA1683, AMPD2 | TIPRL | PPP4C, PPP4R2, PPP2CB, PPP6C, CUL3, APP, PRDX1, PRDX2, SORD, SSU72, XPNPEP1, ATP6V1A, METTL21B, LMNA, HUWE1, PPP2CA, IGBP1, ARHGAP44, MCMBP, NPEPL1, SH3BP1, ACAD10, COMMD2, COMMD4, CORO1B, CORO1C, CSE1L, EIF4A3, GDA, GOLPH3, IARS, LARS, MSH2, PLCG1, PPP6R3, SRM, TPP2, UCHL5, UROD, NTRK1, DUSP8, FUCA1, ITLN1, PTPDC1, DYNLT1, TCTEX1D2 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for NME7_TIPRL |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for NME7_TIPRL |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | NME7 | C0236969 | Substance-Related Disorders | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|